Harwaypharma Co., Ltd., founded in 2017, is a national "specialized and new" small giant enterprise, a national "chemical medicine CDMO integrated service platform" demonstration enterprise, a champion of Shandong's single manufacturing industry, a provincial gazelle enterprise, a provincial technology giant enterprise, and a provincial service industry innovation center. It is a national high-tech enterprise integrating research, development, production and sales of chemical raw materials, pharmaceutical intermediates and fine chemicals.
The production base of Harwaypharma covers an area of 1000 mu. The technical center of the company is equipped with AVANCE NEO 400 nuclear magnetic resonance instrument, LC-MS, GC-MS and other experimental instruments, which can realize the research and commercialization of small molecular drugs from gram level, kilogram level to ton level. To build the integration of "pharmaceutical intermediates - raw materials - preparations" of generic drugs as the "goal of the 10th anniversary of the establishment of the factory"; The "core competitiveness goal" is to build the "discovery, research and development, commercialization" pipeline model of innovative drugs.
The company will adhere to the vision and mission of "innovation and entrepreneurship for human health, develop and produce domestic reassuring drugs that people can eat, can afford, and can eat well", and implement the core values of "sharing the same ideals, reaching the world; cultivating benevolence, and pursuing good deeds", and jointly create the future with partners!
more >
Year of Establishment:
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
Main Sales Markets:
Other Competitive Advantages:
Patents and Copyrights: